Avacopan — Dosing in CKD & Dialysis
Avacopan (Complement 5a Receptor (C5aR) Antagonist): renal dosing adjustments, dialyzability (Not studied in the label (no dialysis statement); plasma protein binding greater than 99.9% (Tavneos label 12.3). Level estimated from molecule size or protein binding; not measured.), and renal-relevant sa
Reviewed by Matt · November 16, 2026